Zhang, Mengqi
Liu, Si
Miao, Zhen
Han, Fang
Gottardo, Raphael
Funding for this research was provided by:
national institute of general medical sciences (GM105785)
Article History
Received: 15 July 2021
Accepted: 6 January 2022
First Online: 24 January 2022
Declarations
:
: Not applicable.
: R.G. has received consulting income from Takeda Vaccines, speaker fees from Illumina and Fluidigm, research support from Janssen Pharmaceuticals, and declares ownership in Ozette Technologies and minor stock ownerships in 10X Genomics, Vir Biotechnology, Abcellera, BioNTech, and Sana Biotechnologies.